On the other hand, mTORC2 signaling has an important role in the development of resistance in PDAC; in fact, its inhibitors have anti-tumor activity in PDAC cells when combined with an inhibitor of KRASmu or MEK [38]. This evidence concerns the gene MAP2K7 and neoplasm.